logo

FDA Calendar

Share
Company Name Achaogen Inc.
Drug Name Plazomicin (NDA)
Event Name FDA decision on Plazomicin for the treatment of complicated urinary tract infections, and bloodstream infections
Event Date 06/25/2018
Outcome Date 06/26/2018
Outcome FDA approved ZEMDRI (plazomicin) on June 26, 2018, only for Complicated Urinary Tract Infections; Stock fell as much as 27%
Drug Status Priority review
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar